Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE)

Anders Juul; Sergio Bernasconi; Jean-Claude Carel; Peter E Clayton; Wieland Kiess; Sabine DeMuinck-Keizer Schrama; Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology

doi:http://dx.doi.org/71879

Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE)

Anders Juul, Sergio Bernasconi, Jean-Claude Carel, Peter E Clayton, Wieland Kiess, Sabine DeMuinck-Keizer Schrama, Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology

12 Citations (Scopus)

Original language	English
Journal	Hormone Research
Volume	60
Issue number	2
Pages (from-to)	103-4
Number of pages	2
ISSN	0301-0163
DOIs	https://doi.org/71879
Publication status	Published - 2003

Access to Document

http://dx.doi.org/71879

Cite this

Juul, A., Bernasconi, S., Carel, J-C., Clayton, P. E., Kiess, W., DeMuinck-Keizer Schrama, S., & Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (2003). Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE). Hormone Research, 60(2), 103-4. https://doi.org/71879

Juul, A, Bernasconi, S, Carel, J-C, Clayton, PE, Kiess, W, DeMuinck-Keizer Schrama, S & Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology 2003, 'Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE)', Hormone Research, vol. 60, no. 2, pp. 103-4. https://doi.org/71879

@article{8377186ae1b14d23bec323ce63c1095b,

title = "Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE)",

author = "Anders Juul and Sergio Bernasconi and Jean-Claude Carel and Clayton, {Peter E} and Wieland Kiess and {DeMuinck-Keizer Schrama}, Sabine and Anders Juul",

year = "2003",

doi = "http://dx.doi.org/71879",

language = "English",

volume = "60",

pages = "103--4",

journal = "Hormone Research",

issn = "0301-0163",

publisher = "S./Karger AG",

number = "2",

}

TY - JOUR

T1 - Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE)

AU - Juul, Anders

AU - Bernasconi, Sergio

AU - Carel, Jean-Claude

AU - Clayton, Peter E

AU - Kiess, Wieland

AU - DeMuinck-Keizer Schrama, Sabine

AU - Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology

PY - 2003

Y1 - 2003

U2 - http://dx.doi.org/71879

DO - http://dx.doi.org/71879

M3 - Review

SN - 0301-0163

VL - 60

SP - 103

EP - 104

JO - Hormone Research

JF - Hormone Research

IS - 2

ER -